|
| Status |
Public on Feb 08, 2019 |
| Title |
UBR7 is a novel E3 ubiquitin ligase for H2BK120 and acts as a tumor-suppressor in breast cancer |
| Organism |
Homo sapiens |
| Experiment type |
Genome binding/occupancy profiling by high throughput sequencing
Expression profiling by high throughput sequencing
|
| Summary |
This SuperSeries is composed of the SubSeries listed below.
|
| |
|
| Overall design |
Refer to individual Series
|
| |
|
| Citation(s) |
30923315 |
| |
| Submission date |
Jan 18, 2017 |
| Last update date |
Nov 07, 2023 |
| Contact name |
Kunal Rai |
| E-mail(s) |
Krai@MDAnderson.org
|
| Phone |
713-792-6809
|
| Organization name |
MD Anderson Cancer Center
|
| Department |
Genomic Medicine
|
| Lab |
Rai Lab
|
| Street address |
1801 East Rd
|
| City |
Houston |
| State/province |
TX |
| ZIP/Postal code |
77054 |
| Country |
USA |
| |
|
| Platforms (1) |
| GPL11154 |
Illumina HiSeq 2000 (Homo sapiens) |
|
| Samples (22)
|
|
| This SuperSeries is composed of the following SubSeries: |
| GSE93757 |
UBR7 is a novel E3 ubiquitin ligase for H2BK120 and acts as a tumor-suppressor in breast cancer [ChIP-Seq] |
| GSE93758 |
UBR7 is a novel E3 ubiquitin ligase for H2BK120 and acts as a tumor-suppressor in breast cancer [RNA-Seq] |
|
| Relations |
| BioProject |
PRJNA362300 |
Less...
More...